ID   PDK4_HUMAN              Reviewed;         411 AA.
AC   Q16654;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial;
DE            EC=2.7.11.2;
DE   AltName: Full=Pyruvate dehydrogenase kinase isoform 4;
DE   Flags: Precursor;
GN   Name=PDK4; Synonyms=PDHK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8798399; DOI=10.1074/jbc.271.37.22376;
RA   Rowles J., Scherer S.W., Xi T., Majer M., Nickle D.C., Rommens J.M.,
RA   Popov K.M., Harris R.A., Riebow N.L., Xia J., Tsui L.-C., Bogardus C.,
RA   Prochazka M.;
RT   "Cloning and characterization of PDK4 on 7q21.3 encoding a fourth
RT   pyruvate dehydrogenase kinase isoenzyme in human.";
RL   J. Biol. Chem. 271:22376-22382(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=14966024; DOI=10.1152/japplphysiol.01318.2003;
RA   Spriet L.L., Tunstall R.J., Watt M.J., Mehan K.A., Hargreaves M.,
RA   Cameron-Smith D.;
RT   "Pyruvate dehydrogenase activation and kinase expression in human
RT   skeletal muscle during fasting.";
RL   J. Appl. Physiol. 96:2082-2087(2004).
RN   [5]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=15955060; DOI=10.1111/j.1742-4658.2005.04713.x;
RA   Abbot E.L., McCormack J.G., Reynet C., Hassall D.G., Buchan K.W.,
RA   Yeaman S.J.;
RT   "Diverging regulation of pyruvate dehydrogenase kinase isoform gene
RT   expression in cultured human muscle cells.";
RL   FEBS J. 272:3004-3014(2005).
RN   [6]
RP   INDUCTION BY PPARD.
RX   PubMed=17669420; DOI=10.1016/j.jmb.2007.06.091;
RA   Degenhardt T., Saramaki A., Malinen M., Rieck M., Vaisanen S.,
RA   Huotari A., Herzig K.H., Muller R., Carlberg C.;
RT   "Three members of the human pyruvate dehydrogenase kinase gene family
RT   are direct targets of the peroxisome proliferator-activated receptor
RT   beta/delta.";
RL   J. Mol. Biol. 372:341-355(2007).
RN   [7]
RP   FUNCTION.
RX   PubMed=21852536; DOI=10.1101/gad.16771811;
RA   Grassian A.R., Metallo C.M., Coloff J.L., Stephanopoulos G.,
RA   Brugge J.S.;
RT   "Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates
RT   cell proliferation.";
RL   Genes Dev. 25:1716-1733(2011).
RN   [8]
RP   INDUCTION.
RX   PubMed=20715114; DOI=10.1002/ijc.25599;
RA   Blouin J.M., Penot G., Collinet M., Nacfer M., Forest C.,
RA   Laurent-Puig P., Coumoul X., Barouki R., Benelli C., Bortoli S.;
RT   "Butyrate elicits a metabolic switch in human colon cancer cells by
RT   targeting the pyruvate dehydrogenase complex.";
RL   Int. J. Cancer 128:2591-2601(2011).
RN   [9]
RP   FUNCTION, INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21816445; DOI=10.1016/j.metabol.2011.06.014;
RA   Kulkarni S.S., Salehzadeh F., Fritz T., Zierath J.R., Krook A.,
RA   Osler M.E.;
RT   "Mitochondrial regulators of fatty acid metabolism reflect metabolic
RT   dysfunction in type 2 diabetes mellitus.";
RL   Metabolism 61:175-185(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 20-411 IN COMPLEX WITH ATP,
RP   FUNCTION, ENZYME REGULATION, SUBUNIT, AND MUTAGENESIS OF TYR-157;
RP   ARG-161; ASP-394 AND TRP-395.
RX   PubMed=18658136; DOI=10.1074/jbc.M802249200;
RA   Wynn R.M., Kato M., Chuang J.L., Tso S.C., Li J., Chuang D.T.;
RT   "Pyruvate dehydrogenase kinase-4 structures reveal a metastable open
RT   conformation fostering robust core-free basal activity.";
RL   J. Biol. Chem. 283:25305-25315(2008).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 20-411 IN COMPLEX WITH ATP
RP   ANALOG, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=21904029; DOI=10.1107/S090744491102405X;
RA   Kukimoto-Niino M., Tokmakov A., Terada T., Ohbayashi N., Fujimoto T.,
RA   Gomi S., Shiromizu I., Kawamoto M., Matsusue T., Shirouzu M.,
RA   Yokoyama S.;
RT   "Inhibitor-bound structures of human pyruvate dehydrogenase kinase
RT   4.";
RL   Acta Crystallogr. D 67:763-773(2011).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-17; MET-19 AND GLY-109.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase that plays a key role in regulation of glucose
CC       and fatty acid metabolism and homeostasis via phosphorylation of
CC       the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits
CC       pyruvate dehydrogenase activity, and thereby regulates metabolite
CC       flux through the tricarboxylic acid cycle, down-regulates aerobic
CC       respiration and inhibits the formation of acetyl-coenzyme A from
CC       pyruvate. Inhibition of pyruvate dehydrogenase decreases glucose
CC       utilization and increases fat metabolism in response to prolonged
CC       fasting and starvation. Plays an important role in maintaining
CC       normal blood glucose levels under starvation, and is involved in
CC       the insulin signaling cascade. Via its regulation of pyruvate
CC       dehydrogenase activity, plays an important role in maintaining
CC       normal blood pH and in preventing the accumulation of ketone
CC       bodies under starvation. In the fed state, mediates cellular
CC       responses to glucose levels and to a high-fat diet. Regulates both
CC       fatty acid oxidation and de novo fatty acid biosynthesis. Plays a
CC       role in the generation of reactive oxygen species. Protects
CC       detached epithelial cells against anoikis. Plays a role in cell
CC       proliferation via its role in regulating carbohydrate and fatty
CC       acid metabolism. {ECO:0000269|PubMed:15955060,
CC       ECO:0000269|PubMed:18658136, ECO:0000269|PubMed:21816445,
CC       ECO:0000269|PubMed:21852536}.
CC   -!- CATALYTIC ACTIVITY: ATP + [pyruvate dehydrogenase (acetyl-
CC       transferring)] = ADP + [pyruvate dehydrogenase (acetyl-
CC       transferring)] phosphate. {ECO:0000269|PubMed:21904029}.
CC   -!- SUBUNIT: Homodimer. Interacts with the pyruvate dehydrogenase
CC       complex subunit DLAT, and is part of the multimeric pyruvate
CC       dehydrogenase complex that contains multiple copies of pyruvate
CC       dehydrogenase (E1), dihydrolipoamide acetyltransferase (DLAT, E2)
CC       and lipoamide dehydrogenase (DLD, E3).
CC       {ECO:0000269|PubMed:18658136, ECO:0000269|PubMed:21904029}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- TISSUE SPECIFICITY: Ubiquitous; highest levels of expression in
CC       heart and skeletal muscle. {ECO:0000269|PubMed:14966024,
CC       ECO:0000269|PubMed:21816445}.
CC   -!- INDUCTION: Up-regulated by prolonged fasting, in glucose-deprived
CC       cells and in response to a high-fat diet. Down-regulated by
CC       insulin. Up-regulated by PPARD. {ECO:0000269|PubMed:14966024,
CC       ECO:0000269|PubMed:15955060, ECO:0000269|PubMed:17669420,
CC       ECO:0000269|PubMed:20715114, ECO:0000269|PubMed:21816445}.
CC   -!- SIMILARITY: Belongs to the PDK/BCKDK protein kinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U54628; AAC50670.1; -; Genomic_DNA.
DR   EMBL; U54618; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54619; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54620; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54621; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54622; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54623; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54624; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54625; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54626; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54627; AAC50670.1; JOINED; Genomic_DNA.
DR   EMBL; U54617; AAC50669.1; -; mRNA.
DR   EMBL; AC002451; AAB67048.1; -; Genomic_DNA.
DR   EMBL; BC040239; AAH40239.1; -; mRNA.
DR   CCDS; CCDS5643.1; -.
DR   RefSeq; NP_002603.1; NM_002612.3.
DR   UniGene; Hs.8364; -.
DR   PDB; 2E0A; X-ray; 1.86 A; A/B=20-411.
DR   PDB; 2ZDX; X-ray; 2.54 A; A/B=20-411.
DR   PDB; 2ZDY; X-ray; 2.40 A; A/B=20-411.
DR   PDB; 2ZKJ; X-ray; 2.00 A; A/B=20-411.
DR   PDB; 3D2R; X-ray; 2.03 A; A/B=20-411.
DR   PDBsum; 2E0A; -.
DR   PDBsum; 2ZDX; -.
DR   PDBsum; 2ZDY; -.
DR   PDBsum; 2ZKJ; -.
DR   PDBsum; 3D2R; -.
DR   ProteinModelPortal; Q16654; -.
DR   SMR; Q16654; -.
DR   BioGrid; 111192; 5.
DR   IntAct; Q16654; 2.
DR   STRING; 9606.ENSP00000005178; -.
DR   BindingDB; Q16654; -.
DR   ChEMBL; CHEMBL4141; -.
DR   GuidetoPHARMACOLOGY; 2144; -.
DR   iPTMnet; Q16654; -.
DR   PhosphoSitePlus; Q16654; -.
DR   BioMuta; PDK4; -.
DR   DMDM; 3183120; -.
DR   EPD; Q16654; -.
DR   PaxDb; Q16654; -.
DR   PeptideAtlas; Q16654; -.
DR   PRIDE; Q16654; -.
DR   DNASU; 5166; -.
DR   Ensembl; ENST00000005178; ENSP00000005178; ENSG00000004799.
DR   GeneID; 5166; -.
DR   KEGG; hsa:5166; -.
DR   UCSC; uc003uoa.4; human.
DR   CTD; 5166; -.
DR   DisGeNET; 5166; -.
DR   GeneCards; PDK4; -.
DR   HGNC; HGNC:8812; PDK4.
DR   HPA; HPA056731; -.
DR   MIM; 602527; gene.
DR   neXtProt; NX_Q16654; -.
DR   OpenTargets; ENSG00000004799; -.
DR   PharmGKB; PA33157; -.
DR   eggNOG; KOG0787; Eukaryota.
DR   eggNOG; COG0642; LUCA.
DR   GeneTree; ENSGT00550000074574; -.
DR   HOGENOM; HOG000164315; -.
DR   HOVERGEN; HBG000511; -.
DR   InParanoid; Q16654; -.
DR   KO; K00898; -.
DR   OMA; PSREPKN; -.
DR   OrthoDB; EOG091G07DJ; -.
DR   PhylomeDB; Q16654; -.
DR   TreeFam; TF314918; -.
DR   BRENDA; 2.7.11.2; 2681.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   SIGNOR; Q16654; -.
DR   ChiTaRS; PDK4; human.
DR   EvolutionaryTrace; Q16654; -.
DR   GeneWiki; PDK4; -.
DR   GenomeRNAi; 5166; -.
DR   PRO; PR:Q16654; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000004799; -.
DR   CleanEx; HS_PDK4; -.
DR   ExpressionAtlas; Q16654; baseline and differential.
DR   Genevisible; Q16654; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; EXP:Reactome.
DR   GO; GO:0071398; P:cellular response to fatty acid; IMP:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; IMP:UniProtKB.
DR   GO; GO:0045124; P:regulation of bone resorption; IEA:Ensembl.
DR   GO; GO:0010565; P:regulation of cellular ketone metabolic process; ISS:UniProtKB.
DR   GO; GO:0042304; P:regulation of fatty acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0046320; P:regulation of fatty acid oxidation; ISS:UniProtKB.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB.
DR   GO; GO:0006885; P:regulation of pH; ISS:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; ISS:UniProtKB.
DR   Gene3D; 1.20.140.20; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR018955; BCDHK/PDK_N.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR005467; His_kinase_dom.
DR   Pfam; PF10436; BCDHK_Adom3; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF69012; SSF69012; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Carbohydrate metabolism; Complete proteome;
KW   Glucose metabolism; Kinase; Mitochondrion; Nucleotide-binding;
KW   Polymorphism; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    411       [Pyruvate dehydrogenase (acetyl-
FT                                transferring)] kinase isozyme 4,
FT                                mitochondrial.
FT                                /FTId=PRO_0000023445.
FT   DOMAIN      138    368       Histidine kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00107}.
FT   NP_BIND     254    261       ATP. {ECO:0000269|PubMed:18658136}.
FT   NP_BIND     312    313       ATP. {ECO:0000269|PubMed:18658136}.
FT   NP_BIND     329    334       ATP. {ECO:0000269|PubMed:18658136}.
FT   BINDING     293    293       ATP. {ECO:0000269|PubMed:18658136}.
FT   SITE        157    157       Interaction with the other subunit in the
FT                                homodimer.
FT   SITE        161    161       Interaction with the other subunit in the
FT                                homodimer.
FT   SITE        395    395       Interaction with the other subunit in the
FT                                homodimer.
FT   VARIANT      17     17       A -> V (in dbSNP:rs56391840).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042298.
FT   VARIANT      19     19       L -> M (in dbSNP:rs55761955).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042299.
FT   VARIANT     109    109       D -> G (in dbSNP:rs34898343).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042300.
FT   MUTAGEN     157    157       Y->F: Loss of activity.
FT                                {ECO:0000269|PubMed:18658136}.
FT   MUTAGEN     161    161       R->A: Loss of activity.
FT                                {ECO:0000269|PubMed:18658136}.
FT   MUTAGEN     394    394       D->A: Loss of activity; when associated
FT                                with A-395.
FT                                {ECO:0000269|PubMed:18658136}.
FT   MUTAGEN     395    395       W->A: Loss of activity; when associated
FT                                with A-394.
FT                                {ECO:0000269|PubMed:18658136}.
FT   HELIX        22     27       {ECO:0000244|PDB:2E0A}.
FT   HELIX        37     42       {ECO:0000244|PDB:2E0A}.
FT   HELIX        50     72       {ECO:0000244|PDB:2E0A}.
FT   HELIX        77     80       {ECO:0000244|PDB:2E0A}.
FT   HELIX        83    100       {ECO:0000244|PDB:2E0A}.
FT   STRAND      103    105       {ECO:0000244|PDB:2E0A}.
FT   HELIX       110    127       {ECO:0000244|PDB:2E0A}.
FT   HELIX       130    142       {ECO:0000244|PDB:2E0A}.
FT   TURN        149    151       {ECO:0000244|PDB:2E0A}.
FT   HELIX       153    180       {ECO:0000244|PDB:2E0A}.
FT   STRAND      194    199       {ECO:0000244|PDB:2E0A}.
FT   HELIX       200    219       {ECO:0000244|PDB:2E0A}.
FT   STRAND      225    234       {ECO:0000244|PDB:2E0A}.
FT   STRAND      240    243       {ECO:0000244|PDB:2E0A}.
FT   HELIX       245    266       {ECO:0000244|PDB:2E0A}.
FT   TURN        267    269       {ECO:0000244|PDB:2E0A}.
FT   STRAND      270    272       {ECO:0000244|PDB:2E0A}.
FT   STRAND      276    282       {ECO:0000244|PDB:2E0A}.
FT   STRAND      284    293       {ECO:0000244|PDB:2E0A}.
FT   HELIX       300    302       {ECO:0000244|PDB:2E0A}.
FT   HELIX       303    306       {ECO:0000244|PDB:2E0A}.
FT   STRAND      329    331       {ECO:0000244|PDB:3D2R}.
FT   HELIX       333    343       {ECO:0000244|PDB:2E0A}.
FT   STRAND      347    353       {ECO:0000244|PDB:2E0A}.
FT   TURN        354    356       {ECO:0000244|PDB:2E0A}.
FT   STRAND      357    367       {ECO:0000244|PDB:2E0A}.
FT   TURN        368    370       {ECO:0000244|PDB:2E0A}.
FT   HELIX       380    385       {ECO:0000244|PDB:2E0A}.
SQ   SEQUENCE   411 AA;  46469 MW;  C17B78B6057000E9 CRC64;
     MKAARFVLRS AGSLNGAGLV PREVEHFSRY SPSPLSMKQL LDFGSENACE RTSFAFLRQE
     LPVRLANILK EIDILPTQLV NTSSVQLVKS WYIQSLMDLV EFHEKSPDDQ KALSDFVDTL
     IKVRNRHHNV VPTMAQGIIE YKDACTVDPV TNQNLQYFLD RFYMNRISTR MLMNQHILIF
     SDSQTGNPSH IGSIDPNCDV VAVVQDAFEC SRMLCDQYYL SSPELKLTQV NGKFPDQPIH
     IVYVPSHLHH MLFELFKNAM RATVEHQENQ PSLTPIEVIV VLGKEDLTIK ISDRGGGVPL
     RIIDRLFSYT YSTAPTPVMD NSRNAPLAGF GYGLPISRLY AKYFQGDLNL YSLSGYGTDA
     IIYLKALSSE SIEKLPVFNK SAFKHYQMSS EADDWCIPSR EPKNLAKEVA M
//
